Autopsy report · NCT03891849

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

“No participant enrolled. Equipment unvailable.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Centre Hospitalier Universitaire, Amiens

Sponsor type

University, hospital or other

Conditions

Haemorrhagic Shock; Variceal Hemorrhage

Interventions

Octreotide Injection

Participants

0

Sites

1

Countries

France

Trials that died the same way

• Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults
  “No participant were enrolled” (79% match in meaning)
• Establishing a New Protocol for Early Mucositis and Peri-implantitis Treatment Using an Air-polishing Device
  “No participant enrolled” (79% match in meaning)
• Pilot Study: Post-Recovery LibEration From Oxygen in Exacerbated COPD
  “No participants were enrolled” (76% match in meaning)
• Hand-sewn and Linear-stapled Roux-en-Y Gastric Bypass: Outcomes
  “No participants enrolled” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.